| Literature DB >> 26695005 |
Ellen W Maclachlan1, Mark G Shepard-Perry1, Paulina Ingo2, James Uusiku2, Ruusa Mushimba3, Ricky Simwanza4, Joseph Likoro5, Laura J Brandt6, Katherine K Thomas7, Claude Kasonka8, Ndapewa Hamunime9, Gabrielle O'Malley1.
Abstract
In order to increase patient active engagement during patient-provider interactions, we developed and implemented patient training sessions in four antiretroviral therapy (ART) clinics in Namibia using a "Patient Empowerment" training curriculum. We examined the impact of these trainings on patient-provider interactions after the intervention. We tested the effectiveness of the intervention using a randomized parallel group design, with half of the 589 enrolled patients randomly assigned to receive the training immediately and the remaining randomized to receive the training 6 months later. The effects of the training on patient engagement during medical consultations were measured at each clinic visit for at least 8 months of follow-up. Each consultation was audiotaped and then coded using the Roter Interaction Analysis System (RIAS). RIAS outcomes were compared between study groups at 6 months. Using intention-to-treat analysis, consultations in the intervention group had significantly higher RIAS scores in doctor facilitation and patient activation (adjusted difference in score 1.19, p = .004), doctor information gathering (adjusted difference in score 2.96, p = .000), patient question asking (adjusted difference in score .48, p = .012), and patient positive affect (adjusted difference in score 2.08, p = .002). Other measures were higher in the intervention group but did not reach statistical significance. We have evidence that increased engagement of patients in clinical consultation can be achieved via a targeted training program, although outcome data were not available on all patients. The patient training program was successfully integrated into ART clinics so that the trainings complemented other services being provided.Entities:
Keywords: ART services; Impact evaluation; empowerment; medical dialogue; patient–provider communication; randomized controlled trial
Mesh:
Year: 2015 PMID: 26695005 PMCID: PMC4841015 DOI: 10.1080/09540121.2015.1124975
Source DB: PubMed Journal: AIDS Care ISSN: 0954-0121
Figure 1. Schematic of patient education and empowerment impact evaluation study design.
Figure 2. Patient education and empowerment study cascade.
Demographic characteristics of the study population by study group.
| Participant characteristic | Intervention | Control |
|---|---|---|
| Demographics | ||
| Female gender | 195 (65%) | 199 (69%) |
| Age – mean (SD) | 34 (8.1) | 34 (8.2) |
| – Median (IQR) | 33 (29–39) | 33 (28–39) |
| Employed | 110 (37%) | 102 (35%) |
| Education | ||
| None | 16 (5%) | 14 (5%) |
| Primary | 83 (28%) | 81 (28%) |
| Secondary | 196 (66%) | 190 (65%) |
| Post-secondary | 4 (1%) | 6 (2%) |
| Marital status | ||
| Single | 155 (52%) | 153 (53%) |
| Married | 67 (22%) | 53 (18%) |
| Separated or divorced | 7 (2%) | 9 (3%) |
| Widowed | 10 (3%) | 9 (3%) |
| Live with partner (unmarried) | 60 (20%) | 66 (23%) |
| Reproductive characteristics | ||
| Using family planning method (women) | 93 (48%) | 87 (44%) |
| Pregnant (women) | ||
| Yes | 28 (14%) | 36 (18%) |
| Don't know | 6 (3%) | 4 (2%) |
| Live births (women) | ||
| –Mean (SD) | 2.11 (1.72) | 2.04 (1.63) |
| –Median (IQR) | 2.0 (1–3) | 2.0 (1–3) |
| Children (men) | ||
| –Mean (SD) | 3.09 (2.15) | 2.93 (2.08) |
| –Median (IQR) | 3.0 (1–4) | 2.0 (2–4) |
| HIV characteristics | ||
| Months since first pos. HIV test | ||
| – Mean (SD) | 17.1 (22.9) | 19.7 (24.4) |
| – Median (IQR) | 5.1 (1.3–26.8) | 6.9 (1.5–33.1) |
| Unknown or missing | 18 (6.0%) | 16 (6.0%) |
| Body mass index (BMI) | ||
| – Mean (SD) | 21.7 (3.7) | 21.8 (4.0) |
| – Median (IQR) | 21.2 (19.1–23.9) | 21.5 (18.8–23.9) |
| Unknown or missing | 65 (21.7%) | 77 (26.6%) |
| Weight (kg) | ||
| – Mean (SD) | 59.2 (10.6) | 59.2 (11.2) |
| – Median (IQR) | 58.0 (52.1–64.0) | 59.0 (52.0–65.0) |
| Unknown or missing | 19 (6.4%) | 24 (8.3%) |
| WHO clinical stage at ART initiation | ||
| Stage 1 | 161 (57%) | 141 (51%) |
| Stage 2 | 71 (25%) | 98 (36%)a |
| Stage 3 | 45 (16%) | 33 (12%) |
| Stage 4 | 3 (1%) | 4 (1%) |
| Unknown or missing | 19 (6.4%) | 13 (4.5%) |
aPearson's chi square (1df), p = .005.
Six month RIAS and global affect measures by study group.
| Patient–provider interaction measure | Group 1, Intervention Mean (SD) | Group 2, Control Mean (SD) | Difference in score (95% CI) | Adjusted differencea (95% CI) | Adjusted | |
|---|---|---|---|---|---|---|
| Doctor RIAS variables | ||||||
| 213 | 180 | |||||
| 160 | 129 | |||||
| Physician verbal dominance | 0.54 (0.12) | 0.55 (0.13) | 0.002 (−0.02, 0.02) | 0.85 | .007 (−0.01, 0.03) | 0.54 |
| Facilitation and patient activation | 5.64 (5.20) | 4.59 (3.86) | 1.10 (0.28, 1.92) | 0.01 | 1.19 (0.39, 1.99) | |
| Doctor positive affect | 4.21 (4.92) | 3.50 (3.55) | 0.66 (−0.14, 1.45) | 0.11 | 0.74 (−0.04, 1.52) | 0.06 |
| Patient centeredness | 1.18 (1.00) | 1.00 (0.99) | 0.12 (−.06, .31) | 0.18 | 0.14 (−0.05, 0.33) | 0.14 |
| Doctor information gathering | 9.52 (9.62) | 7.00 (7.28) | 2.81 (1.23, 4.39) | 0.000 | 2.96(1.42, 4.50) | |
| Patient RIAS variables | ||||||
| All patient question asking | 2.10 (1.53) | 1.05 (1.44) | 0.51 (0.12, 0.89) | 0.01 | 0.48 (0.11, 0.85) | |
| Patient activation and engagement | 0.91 (1.38) | 0.98 (1.36) | 0.02 (−0.26, 0.30) | 0.90 | 0.03 (−0.25, 0.32) | 0.81 |
| Patient positive affect | 8.94 (8.77) | 6.68 (6.40) | 2.11 (.80, 3.42) | 0.002 | 2.08 (0.79, 3.36) | |
| Global affect | ||||||
| N observations | 207 | 174 | ||||
| N participants | 159 | 127 | ||||
| Doctor global affect | ||||||
| Positive affect | 10.73 (2.76) | 10.21 (2.76) | .60 (.08, 1.12) | 0.024 | 0.60 (0.08, 1.11) | |
| Dominance/assertiveness | 3.36 (.74) | 3.30 (.73) | .07 (−.05, .18) | 0.25 | 0.07 (−0.04, 0.18) | 0.22 |
| Interactivity | 3.67 (.77) | 3.57 (.73) | .13(−.01, .27) | 0.07 | 0.13(−0.005, 0.26) | 0.06 |
| Patient global affect | ||||||
| Positive affect | 14.75 (3.05) | 14.37 (2.84) | .34 (−.17, .85) | 0.19 | 0.33(−0.16, 0.83) | 0.19 |
| Interactivity | 3.34 (.87) | 3.28 (.79) | .09 (−.06, .24) | 0.23 | 0.09(−0.05, 0.23) | 0.22 |
aAdjusted for site, length of consultation, nurse versus doctor, provider, provider sex, patient gender, and whether an interpreter was present.